SCHEMBL275445

SCHEMBL275445

O=C(Cl)C(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180158 0.79
SCHEMBL140291 0.75
SCHEMBL12305761 0.75
SCHEMBL7338051 0.72 EGLN1 (0.37)
Bromide SCHEMBL28255766 0.72
SCHEMBL13478061 0.72 CA4 (0.38)
SCHEMBL4644763 0.72
SCHEMBL29087178 0.69
SCHEMBL17318054 0.69
SCHEMBL11232653 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3547836-B1 A PERILLYL ALCOHOL-3 BROMOPYRUVATE CONJUGATE AND METHODS OF TREATING CANCER UNIV SOUTHERN CALIFORNIA (US) 2024-08-21 EP claimed
CN-110267538-B Perilla alcohol-3-bromopyruvate conjugates and methods of treating cancer 尼昂克技术公司 2022-04-19 CN claimed
US-10858305-B2 Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer Neonc Technologies, Inc. (US) 2020-12-08 US claimed
US-20190337884-A1 A PERILLYL ALCOHOL-3-BROMOPYRUVATE CONJUGATE AND METHODS OF TREATING CANCER UNIVERSITY OF SOUTHERN CALIFORNIA 2019-11-07 US claimed
EP-3547836-A1 A PERILLYL ALCOHOL-3 BROMOPYRUVATE CONJUGATE AND METHODS OF TREATING CANCER Neonc Technologies Inc. (US) 2019-10-09 EP claimed
WO-2018102412-A1 A PERILLYL ALCOHOL-3 BROMOPYRUVATE CONJUGATE AND METHODS OF TREATING CANCER Neonc Technologies, Inc. (US) 2018-06-07 WO claimed
EP-3547836-B1 A PERILLYL ALCOHOL-3 BROMOPYRUVATE CONJUGATE AND METHODS OF TREATING CANCER UNIV SOUTHERN CALIFORNIA (US) 2024-08-21 EP disclosed
WO-2022250569-A1 NOVEL COMPOUND FOR TREATING BILIARY TRACT DISORDERS ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ВАЛЕНТА-ИНТЕЛЛЕКТ" 2022-12-01 WO disclosed
WO-2022250569-A1 NOVEL COMPOUND FOR TREATING BILIARY TRACT DISORDERS ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ВАЛЕНТА-ИНТЕЛЛЕКТ" 2022-12-01 WO disclosed
CN-110267538-B Perilla alcohol-3-bromopyruvate conjugates and methods of treating cancer 尼昂克技术公司 2022-04-19 CN disclosed
US-10858305-B2 Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer Neonc Technologies, Inc. (US) 2020-12-08 US disclosed
US-20190337884-A1 A PERILLYL ALCOHOL-3-BROMOPYRUVATE CONJUGATE AND METHODS OF TREATING CANCER UNIVERSITY OF SOUTHERN CALIFORNIA 2019-11-07 US disclosed
EP-3547836-A1 A PERILLYL ALCOHOL-3 BROMOPYRUVATE CONJUGATE AND METHODS OF TREATING CANCER Neonc Technologies Inc. (US) 2019-10-09 EP disclosed
WO-2007070796-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2007-06-21 WO disclosed
EP-1692136-A2 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS X-Ceptor Therapeutics, Inc. (US) 2006-08-23 EP disclosed
WO-2005056554-A2 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2005-06-23 WO disclosed
EP-1532153-A1 AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS X-Ceptor Therapeutics, Inc. (US) 2005-05-25 EP disclosed
US-20050054634-A1 Modulating active of receptors; therapy prevention of disease such aas symthrome X, antidiabetic agents, insulin resistance, hypoglycemic agents AKARNA THERAPEUTICS, LTD. (GB) 2005-03-10 US disclosed
US-20040023947-A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents X-CEPTOR THERAPEUTICS INC. 2004-02-05 US disclosed
WO-2003099821-A1 AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS X-CEPTOR THERAPEUTICS, INC. (US) 2003-12-04 WO disclosed